The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma

Journal of Immunoassay
I C Robinson

Abstract

The development and evaluation of a radioimmunoassay for oxytocin is described. High titre antisera were raised to oxytocin coupled to thyroglobulin and tested for specificity with a number of oxytocin analogues and fragments. Two antisera showing high specificity were used to assay plasma directly without extraction. The maximum sensitivity was 0.5pg per tube and the intra- and inter-assay co-efficients of variation were 7.1 and 11.6% respectively. Cross-reactivity studies indicate that the antisera were directed chiefly to the oxytocin side-chain. The antisera could be purified by affinity chromatography using this tripeptide coupled to agarose beads but this did not improve their avidity or specificity. The assay was tested successfully with a number of body fluids and tissue extracts, although human late-pregnancy plasma could not be added directly to the assay. Direct radioimmunoassay was used to estimate the clearance of oxytocin infused into conscious dogs, and good agreement was found when the same samples were also bioassayed. The antisera also efficiently neutralise the biological activity of oxytocin in vivo and in vitro.

References

Feb 1, 1979·The Journal of Endocrinology·I C Robinson, J M Walker
Apr 1, 1979·The Journal of Endocrinology·W A LuqmanM L Smith
Feb 1, 1978·The Journal of Endocrinology·M Y DawoodC Pociask
Feb 1, 1978·Horumon to rinsho. Clinical endocrinology·T SudoM Sawai
Apr 1, 1978·Clinical Endocrinology·R W StevensonK G Alberti
Nov 1, 1977·Endocrinology·G MooreK Lederis
May 1, 1976·Immunochemistry·P CzernichowJ Ronne
Mar 1, 1974·British Journal of Pharmacology·I C Robinson, J M Walker
May 15, 1974·American Journal of Obstetrics and Gynecology·P KumaresanA Vasicka
Oct 1, 1971·Endocrinology·R Walter, H Shlank
Jul 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·M E CelisR Walter
Apr 1, 1970·The Journal of Clinical Investigation·H Vorherr, R A Munsick
Oct 1, 1963·The Biochemical Journal·F C GREENWOODJ S GLOVER

❮ Previous
Next ❯

Citations

Nov 1, 1991·Cell and Tissue Research·G F JirikowskiC A Pedersen
Apr 1, 1987·Journal of in Vitro Fertilization and Embryo Transfer : IVF·J C PeekF M Graham
Apr 1, 1985·Brain Research·G ValiquetteE A Zimmerman
Sep 1, 1990·Pharmacology, Biochemistry, and Behavior·D M WittD M Walton
Jan 1, 1986·Psychoneuroendocrinology·W G HonerS A Checkley
Jan 1, 1987·Psychoneuroendocrinology·D A Carter, S L Lightman
Aug 14, 1982·Lancet·L J WhalleyG Fink
Jan 1, 1985·Journal of Immunoassay·J M BurdP H Baylis
Jul 1, 1985·Acta Physiologica Scandinavica·K Uvnäs-MobergA Kunavongkrit
Oct 1, 1985·Acta Physiologica Scandinavica·S Stock, K Uvnäs-Moberg
Apr 1, 1986·Acta Physiologica Scandinavica·H Vilhardt, S Lundin
Jul 1, 1992·Acta Physiologica Scandinavica·S E AndersenP Bie
Jan 22, 1983·British Medical Journal·A S McNeillyP W Howie
Nov 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·C J Poole, S L Lightman
Nov 1, 1983·Clinics in Endocrinology and Metabolism·P H Baylis
Oct 2, 2007·Theriogenology·M KlarenbeekM A M Taverne
Feb 1, 1986·Neuropeptides·J D CaldwellC A Pedersen
May 1, 1985·Clinical Endocrinology·T D WilliamsS L Lightman
May 15, 2013·Neuroscience and Biobehavioral Reviews·Michael E McCulloughArmando J Mendez
Apr 1, 1988·Neuropeptides·V J Choy, W B Watkins
Oct 12, 2017·Biological Research for Nursing·Lois C HowlandCynthia D Connelly
Jan 1, 1982·Annals of the New York Academy of Sciences·I C RobinsonJ A Parsons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.